Markets:

Overview

News

Currencies

International

Treasuries

Viking Therapeutics, Inc. - Common Stock (NQ:VKTX)

38.22 -0.89 (-2.28%)

Streaming Delayed Price Updated: 4:00 PM EST, Nov 17, 2025 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Viking Therapeutics, Inc. - Common Stock

< Previous 1 2

...

16 17 18 19 20 21 22 23 24

...

28 29 Next >

2 Soaring Growth Stocks That Could Climb Another 47% to 73%, According to Wall Street ↗

March 26, 2024

Find out why investment banks up and down Wall Street have big expectations for these stocks.

Via The Motley Fool

Wall Street’s Favorite Biotech Stocks? 3 Names That Could Make You Filthy Rich ↗

March 25, 2024

Some of the market’s favorite biotech stocks have created immense wealth, as evidenced with the recent weight-loss drug stock boom.

Via InvestorPlace

Novo Nordisk and Eli Lilly May Finally Have Some Real Competition ↗

March 25, 2024

Novo Nordisk and Eli Lilly dominate the weight-loss market, but progress from a rising biotech could spell trouble for the pharma giants.

Via The Motley Fool

Is Viking Therapeutics Stock a Millionaire Maker? ↗

March 24, 2024

Viking Therapeutics has become one of the hottest healthcare stocks of 2024.

Via The Motley Fool

Where Will Viking Therapeutics Stock Be in 10 Years? ↗

March 23, 2024

Viking's future appears to be very promising, but market dynamics can change.

Via The Motley Fool

2 Incredible Growth Stocks to Buy Right Now ↗

March 20, 2024

These two biotech stocks could be big winners in the years ahead.

Via The Motley Fool

Viking Therapeutics Unusual Options Activity For March 19 ↗

March 19, 2024

Via Benzinga

Warning: This Skyrocketing Stock Has a Hidden Risk ↗

March 19, 2024

Don't bet on this pitfall happening, but know that it's a possibility.

Via The Motley Fool

With Shares Trading Near All-Time Highs, Is Now the Time to Take Profits in Novo Nordisk? ↗

March 22, 2024

The success of Ozempic and Wegovy has fueled Novo Nordisk stock to new highs.

Via The Motley Fool

Could Viking Therapeutics Become the Next Eli Lilly? ↗

March 22, 2024

Viking shares have skyrocketed on its recent good news.

Via The Motley Fool

Viking Therapeutics Stock Has 55% Upside, According to 1 Wall Street Analyst ↗

March 21, 2024

The company might enter the hottest segment in the pharmaceutical sphere before long.

Via The Motley Fool

10 Health Care Stocks With Whale Alerts In Today's Session ↗

March 20, 2024

Via Benzinga

10 Health Care Stocks With Whale Alerts In Today's Session ↗

March 19, 2024

Via Benzinga

Where Will Viking Therapeutics Be in 5 Years? ↗

March 17, 2024

Expectations for the stock are high, and it could well deliver.

Via The Motley Fool

Will Viking Therapeutics Get Acquired? ↗

March 16, 2024

Would an acquisition be good news for Viking Therapeutics investors?

Via The Motley Fool

Check Out What Whales Are Doing With VKTX ↗

March 14, 2024

Via Benzinga

Madrigal Pharmaceuticals Wins Approval for the First Drug Targeting the Multibillion-Dollar NASH Market. Is the Stock a Screaming Buy? ↗

March 17, 2024

Madrigal's Rezdiffra will have the NASH market all to itself -- at least for a while.

Via The Motley Fool

2 Stocks That Have More Than Tripled This Year: Are They Buys? ↗

March 15, 2024

Don't jump on the bandwaggon too quickly.

Via The Motley Fool

Should Pfizer Acquire Viking Therapeutics to Take on Eli Lilly and Novo Nordisk in the Obesity Drug Market? ↗

March 15, 2024

Viking Therapeutics just might be an attractive acquisition target for Pfizer.

Via The Motley Fool

7 Biotech Stocks to Buy as Sector Rotation Ramps Up ↗

March 13, 2024

With digital innovation possibly getting overextended, now’s the time to consider biotech stocks for an incoming rotation.

Via InvestorPlace

Peering Into Viking Therapeutics's Recent Short Interest ↗

March 13, 2024

Via Benzinga

If You Invested $100 In This Stock 5 Years Ago, You Would Have $900 Today ↗

March 11, 2024

Via Benzinga

Is Viking Therapeutics Stock a Buy? ↗

March 11, 2024

Its potential is looking increasingly more likely to be realized.

Via The Motley Fool

Unleashing the Bulls: 3 Top Stocks to Charge Ahead in March ↗

March 13, 2024

This environment presents a compelling opportunity for investors seeking growth. Discover 3 top stocks primed for long-term growth in 2024.

Via InvestorPlace

Could Viking Therapeutics Challenge Giant Eli Lilly in the Billion-Dollar Weight-Loss Drug Market? ↗

March 13, 2024

Viking aims to enter a market that may be worth $100 billion in a few years.

Via The Motley Fool

1 Big New Reason to Buy Novo Nordisk Stock Hand Over Fist Right This Instant ↗

March 12, 2024

The pharma giant could have yet another knockout obesity drug on the way.

Via The Motley Fool

What's Going On With Viking Therapeutics (VKTX) Stock? ↗

March 11, 2024

Viking Therapeutics shares are trading lower by 10.9% Monday afternoon. The stock has experienced marked volatility following a number of key company announcements in February.

Via Benzinga

Missed Out on Eli Lilly and Novo Nordisk? This Could Be the Next Big Weight Loss Stock. ↗

March 09, 2024

Viking Therapeutics has a promising anti-obesity treatment that is generating a lot of interest.

Via The Motley Fool

3 Stock Winners That Are Up 1,000% or More in 2024 ↗

March 08, 2024

Dig deep enough, and find a story hot enough, and you can uncover potential stock winners up 1,000%. Here are three.

Via InvestorPlace

9 Health Care Stocks Whale Activity In Today's Session ↗

March 08, 2024

Via Benzinga

< Previous 1 2

...

16 17 18 19 20 21 22 23 24

...

28 29 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

Viking Therapeutics, Inc. - Common Stock (NQ:VKTX)

All News about Viking Therapeutics, Inc. - Common Stock

Starting at $3.75/week.

Subscribe Today